Europe gears up for future pandemics with AI-powered “PAIR” project

The new EU-funded five-year project PAIR just kicked off in Copenaghen with the participation of 20 partners from 7 countries.

Evotec enters partnership with Charité to expand molecular patient database in autoimmune diseases – Biotech Investments

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec enters partnership with Charité to expand molecular patient database in autoimmune diseases 14.12.2023 / 07:30 CET/CEST The

December 15, 2023

FDA approves J&J and Legend’s Carvykti for second-line multiple myeloma

The FDA has expanded the label for Johnson & Johnson and Legend Biotech’s multiple myeloma CAR-T therapy to make it a much earlier treatment option

April 7, 2024

Formycon and Fresenius Kabi receive European Commission approval for FYB202/Otulfi® (ustekinumab) for the treatment of serious inflammatory diseases – Biotech Investments

EQS-News: Formycon AG / Key word(s): Regulatory Approval/Miscellaneous Formycon and Fresenius Kabi receive European Commission approval for FYB202/Otulfi® (ustekinumab) for the treatment of serious inflammatory

September 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.